Physician

Adam John Ringler, D.P.M.

According to 2025 Medicare claims, Adam Ringler, D.P.M. (NPI: 1407813082) practices podiatry in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is FLORIDA FOOT & ANKLE ASSOCIATES, LLC (NPI: 1861506479; TIN: 141941024) and primary practice location at 33013-3804.

Ringler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 169 traditional Medicare patients, billed 575 HCPCS/CPT codes, and received $37,336 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,313 prescription claims across 430 beneficiaries totaling $92,682 in drug costs, led by Ketoconazole (Ketoconazole). 2022 DME data shows 32 claims. Open Payments data shows 17 records totaling $4,215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $74,378 to $37,336. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $102,473 and ending at $92,682. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	527	1,832	$74,378
2016	578	2,115	$82,817
2017	583	1,866	$69,952
2018	515	1,617	$66,882
2019	368	1,096	$50,855
2020	153	506	$34,224
2021	198	684	$93,363
2022	198	701	$43,746
2023	187	603	$38,332
2024	169	575	$37,336

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	569	2,457	$102,473
2016	608	2,638	$132,194
2017	488	1,920	$114,162
2018	528	2,023	$110,242
2019	558	2,347	$110,859
2020	438	1,869	$79,003
2021	501	2,032	$81,245
2022	602	2,971	$131,628
2023	587	2,945	$178,093
2024	430	2,313	$92,682

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	94	94	$11,395
2016	74	74	$9,068
2017	82	82	$9,933
2018	92	92	$62,404
2019	283	283	$690,526
2020	48	48	$6,143
2021	35	35	$4,536
2022	32	32	$4,165
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	30	34	$106
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	25	25	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	75	173	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	23	137	$65
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	63	97	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ketoconazole	Ketoconazole	925	30,908	$16,371
Ciclopirox	Ciclopirox	356	10,814	$14,882
Ammonium Lactate	Ammonium Lactate	648	23,104	$13,455
Santyl	Collagenase Clostridium Hist.	25	750	$11,502
Betamethasone Dipropionate	Betamethasone Dipropionate	26	840	$1,296

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$4,215	Acera Surgical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam John Ringler, D.P.M.?

Tedicare shows public-source Medicare data for Adam John Ringler, D.P.M. (NPI 1407813082), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam John Ringler, D.P.M. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam John Ringler, D.P.M.?

Adam John Ringler, D.P.M. is linked to FLORIDA FOOT & ANKLE ASSOCIATES, LLC (billing NPI 1861506479) in the available physician profile data.

Does Adam John Ringler, D.P.M. have Open Payments data?

Adam John Ringler, D.P.M. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.